The Middle EAST Non-Invasive Liquid Biopsy Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.00%. This growth trajectory is underpinned by several key factors, including the increasing prevalence of cancer, advancements in liquid biopsy technologies, and a growing preference for non-invasive diagnostic methods among...